Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Colin Fitzpatrick has a total of 114 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The characteristics of men who have sex with men presenting with oral syphilis: a systematic review

    by Amber Savary-Trathen, Zoe Constantinou, Harry Horton-Hill, Julian Robinson, Colin Fitzpatrick, Deborah Williams, Daniel Richardson

    The aim of this systematic review was to highlight the demographic, behavioural, co-infection and clinical characteristics of MSM presenting with oral syphilis. Four bibliographic databases (MEDLINE via Ovid, Embase via Ovid, Cochrane CENTRAL, and CINAHL) was conducted in August 2025. Manuscripts describing MSM with oral syphilis were included in any language. Two reviewers independently screened full-texts for eligibility, and narratively synthesised data. Risk of bias was assessed using the Joanna-Briggs toolkit. The review was registered on PROSPERO (CRD420251106205). A total of 34 manuscripts were included in this review, which included 47 MSM with oral syphilis, and their median age was 29 years (IQR = 26–37). This review highlighted specific demographic (living with HIV), behavioural (oral sex, condomless anal sex, biting, multiple and non-regular sexual partners, recreational drug use/chemsex), co-infection (new HIV diagnosis, previous syphilis, concurrent sexually transmitted infections, other infections) characteristics of MSM with oral syphilis. The clinical features of oral syphilis included painful and painless; tonsillar, lip, tongue, buccal lesions; and with/without lymphadenopathy. Seventeen of the MSM in this review were unnecessarily investigated for a malignancy involving biopsy and histological examination. Oral syphilis has heterogenous clinical presentations, and these data serve as an important resource for future clinical guidelines, research and public health interventions.

  • Enteric infections as HIV indicator conditions for HIV testing: An umbrella review

    by Lucy Rabuszko, Jodie Crossman, Tara Casey, Joe Parvin, Colin Fitzpatrick, Deborah Williams, Dan Clutterbuck, John White, Jonathan Underwood, Daniel Richardson

    Objective: The aim of this umbrella review was to explore whether faeco‐oral sexually transmissible enteric infections should be indicator conditions for HIV testing. Method: Four bibliographical databases (Medline, Emcare, Embase, CINAHL) were searched in May 2026 for systematic reviews written in English, exploring HIV in people with faeco‐oral sexually transmissible enteric infections. Two authors independently reviewed full‐text publications, assessed risk of bias (Joanna Briggs toolkit) and performed a narrative synthesis to identify characteristics relevant to HIV indicator condition testing. Results were reported using the PRIOR guidelines and the review was registered on PROSPERO (ID:CRD420261387222). Results: There were 15 manuscripts in this umbrella review, all of which included study populations consisting exclusively of men who have sex with men (MSM). There were 10 032 MSM across 207 manuscripts that explored Shigella spp., Campylobacter spp., diarrhoeagenic E. coli , Salmonella spp., Giardia duodenalis , Entamoeba histolytica , Hepatitis A, Cryptosporidium spp., hepatitis E, Strongyloides stercoralis , Enterobius vermicularis , intestinal spirochaetosis ( Brachyspira spp.), Blastocystis spp. and enteric viruses. Living with HIV was observed in MSM with all enteric infections. Having a new diagnosis of HIV was seen in MSM with hepatitis A. Having Hepatitis B, Hepatitis C, syphilis and other (or previous) sexually transmitted infections (STI); visiting sex on premises venues, and engaging in chemsex were also observed in MSM with enteric infections. Conclusion: These data provide the best evidence to date that faeco‐oral sexually transmissible enteric infections in MSM are indicator diseases for HIV testing and testing for syphilis, hepatitis B and C and other STIs.

  • Baseline HIV genotypic resistance testing in patients newly diagnosed with HIV : When do we need to consider baseline integrase resistance testing for everyone?

    by Inessa Alekseeva, Natalie Woods, Amber Savary‐Trathen, Claire Norcross, Daniel Richardson, Colin Fitzpatrick

    Background: We aimed to describe baseline drug resistance in patients newly diagnosed with HIV in Brighton over a 12‐year period. Method: As part of a quality improvement project, clinic data were collected for all patients newly diagnosed with HIV between January 2014 and December 2025. Locally, baseline genotypic resistance testing is routinely performed at diagnosis and assessed for resistance to nucleos(t)ide reverse transcriptase inhibitors (NRTIs), non‐nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs). Since 2022, baseline resistance for integrase inhibitors (INIs) has also been performed. Transmitted drug resistance mutations for NRTIs, NNRTIs and PIs were defined according to the World Health Organization (WHO) criteria. Integrase resistance mutations were identified using the Stanford HIV Drug Resistance Database. Extracted data included patient demographics, date of HIV diagnosis, HIV subtype and previous HIV pre‐exposure prophylaxis (HIV‐PrEP) use. Results: Three hundred and eighteen individuals newly diagnosed with HIV throughout the study period, of which 312 had a resistance report available for analysis. Overall, baseline drug resistance was found in 38/312 (12%, 95% CI 8.76–16.33). The median age was 37 years (IQR 30–46). 13 (39%) patients were non‐UK born and 17 (52%) had a non‐B subtype. There were 12 (4%) individuals with NRTI resistance mutations, 13 (4%) with NNRTI mutations and 5 (2%) with PI mutations. Integrase resistance mutations were found in 8/73 (11%) between 2022 and 2025, 3 of whom had no other class resistance. Baseline drug resistance was associated with non‐clade B genotypes (OR = 2.79, 95%CI = 1.34–5.79, p = 0.006) and previous HIV‐PrEP use (OR = 4.14, 95%CI = 1.66–10.4, p = 0.003). Conclusion: This manuscript identified a number of cases where baseline integrase resistance was identified. These data suggest that more work is needed to establish whether baseline integrase inhibitor resistance testing is warranted in all individuals newly diagnosed with HIV.

  • Open Access

    The Aetiology and Treatment Outcomes of Epididymo-Orchitis: A 2025 Clinic-Based Review

    by Jim Abi Frem, Peter Soliman, Colin Fitzpatrick, Deborah Williams, Daniel Richardson

    Background: Epididymo-orchitis can be caused by sexually transmitted pathogens, including Neisseria gonorrhoeae, Chlamydia trachomatis, and Mycoplasma genitalium, or entero-bacteria. The aim of this study was to explore the demographics, microbiological findings, and treatment outcomes of patients presenting to a tertiary sexual health clinic with epididymo-orchitis. Methods: We reviewed the clinical notes of 200 randomly selected patients seen in the clinic with a diagnosis of epididymo-orchitis between 2021 and 2025. We extracted data on demographics, microbiological findings, follow-up, and clinical response rate to treatment. Results: The median age was 33 years (Interquartile range (IQR) = 24–44), 97 (49%) identified as MSM, 11 (6%) were living with HIV (all MSM), and 55 out of the 86 HIV-negative MSM (64%) were using HIV pre-exposure prophylaxis. In total, 35 (18%, 95% confidence intervals = 12.5–23.5%) people were diagnosed with a causative organism: 17 (9%) C. trachomatis, 10 (5%) N. gonorrhoeae, 7 (4%) M. genitalium, 3 (2%) Escherichia coli. Overall, 91 out of 200 (46%) had a documented partner notification plan. Conclusions: A minority of men attending our sexually transmitted infection clinic with clinical epididymo-orchitis have positive microbiology, including M. genitalium. More work is needed to understand the clinical pathophysiology of epididymo-orchitis to streamline treatment algorithms.


  • Are editors and authors ensuring the use of People-First-Charter language?

    by Laurie Smith, Klaudia Serwin, Deborah Williams, Colin Fitzpatrick, Daniel Richardson


  • Gastrointestinal Escherichia coli in men who have sex with men: A systematic review

    by Jim Abi Frem, Annie Russell, Colin Fitzpatrick, Deborah Williams, Daniel Richardson

    Objective: This systematic review aimed to explore any demographic, biological and behavioural characteristics of men who have sex with men (MSM) with diarrhoeagenic E.coli. Design/Methods: We searched MEDLINE, EMBASE, and CINAHL for manuscripts published to March 2024. One author screened manuscript abstracts; two authors independently conducted a full text review. We only included primary data on gastrointestinal E.coli in MSM. Risk of bias was assessed independently by two authors using the Joanna Briggs Institute tools. This review was registered on PROSPERO(CRD42023455321). Results: Eleven manuscripts (cross-sectional studies ( n = 8), case-series ( n = 1), case-control study ( n = 1), longitudinal study ( n = 1)) from Europe ( n = 7) Australia ( n = 2), USA ( n = 2) including 983 MSM with gastrointestinal E.coli published between 2014–2023 were included in this review. Demographic factors (living with HIV, using HIV-PrEP, using dating apps and working as airline crew, group sex, non-regular (casual) sexual partners); behavioural factors (non-regular sexual partners, non-condom use, oro-anal sex, penile-anal sex, use of sex toys, insertive and receptive fisting, scat play); and infection factors (co-infection with Chlamydia trachomatis including LGV, Neisseria gonorrhoeae, Treponema pallidum, hepatitis C, other enteric pathogens [ Shigella spp. Giardia duodenalis, Entamoeba histolytica, hepatitis A and intestinal spirochaetosis]) were observed in MSM with E. coli. Antimicrobial resistance (extended spectrum beta-lactamase and quinolone resistance) was described in MSM with E.coli. Conclusion: We have highlighted demographic, behavioral and infection factors observed in MSM with E.coli suggesting sexual transmissibility. These data provide insight for future clinical guidelines, public health control strategies and research.


  • InvasiveNeisseria meningitidissubtype C in gay, bisexual and other men who have sex with men: a systematic review

    by Lucy Rabuszko, Sarah Stuart-George, Callum Chessell, Colin Fitzpatrick, Deborah Williams, Daniel Richardson

    Introduction: Outbreaks of invasiveNeisseria meningitidissubtype C in networks of gay, bisexual and other men who have sex with men (MSM) have been reported. We aimed to explore any factors seen in MSM with invasiveN.meningitidissubtype C.Method: We searched three bibliographical databases for manuscripts written in English exploring at least one factor seen in MSM with invasiveN. meningitidissubtype C published up to May 2024. Following an initial search, removal of duplicates and abstract review, two authors independently reviewed full-text manuscripts and performed a risk of bias assessment using the Joanna Briggs Institute toolkit. Narrative data were synthesised to generate themes.Results: 16 manuscripts were included in this review from the USA (n=10), Germany (n=2), France (n=2), Canada (n=1) and Italy (n=1) and consisted of nine case series, four cross-sectional studies, two case reports and one case–control study published between 2003 and 2024 involving 236 MSM with invasiveN. meningitidissubtype C, of which at least 64 died. We have highlighted some demographic (African-American or Hispanic identity in the USA, living with HIV), behavioural (kissing, sharing drinks, visiting sex-on-premises venues, visiting gay-oriented venues, using websites/mobile phone apps to meet sexual partners, recreational drug use, multiple and non-regular sexual partners) and infection (previousChlamydia trachomatis, Treponema pallidum, Neisseria gonorrhoeae, Mpox) factors in MSM with invasiveN. meningitidissubtype C.Conclusion: These data serve as an important resource to inform and target future public health strategies and outbreak control measures for the prevention of invasiveN. meningitidissubtype C in MSM.PROSPERO registration number: CRD42024543551.


  • Open Access

    Impact of omission of routine blood monitoring of stable patients living with HIV during the coronavirus pandemic

    by Eleanor Swift, George Upton, Colin Fitzpatrick, Jonathan Roberts, Yvonne Gilleece, Amanda Clarke

    Introduction: The British HIV Association (BHIVA) guidelines were amended during the coronavirus (COVID‐19) pandemic, allowing for less frequent monitoring of routine bloods. We assessed the impact of this on patient outcomes.Methods: Between April 2020 and March 2021, routine blood appointments at our HIV clinic were replaced by virtual consultations in ‘stable’ people living with HIV (PLWH), defined using standard operating procedure (SOP) criteria. All had an undetectable HIV viral load (VL) (<50 copies/mL). Demographic, HIV clinical information, and antiretroviral treatment (ART) data were collated using the electronic patient record (EPR). Blood results from before (baseline) and after (follow‐up) the omitted appointment were analysed for each parameter.Results: In all, 791/2395 PLWH were scheduled to have blood tests omitted; 381 were excluded for reasons including not fitting the SOP criteria or presenting to clinic early, and 410 were included in analysis. The demographics of the group were consistent with our whole HIV cohort. HIV VL became detectable in 8/410 individuals (1.95%, range 51–730 copies/mL). VL resuppressed in 6/8 after a median of 29 days. VL remained detectable in two individuals, both of whom remain in care. Routine blood monitoring revealed baseline and follow‐up blood parameters that were largely within normal range. Four out of 12 parameters had statistically significant changes but were not considered clinically significant; 59/410 (14.4%) changed ART, most commonly for simplification.Conclusion: For the majority of stable PLWH included in our evaluation, the omission of routine blood monitoring during the pandemic did not have a negative impact on HIV suppression or blood monitoring outcomes. ART switch was uncommon.

  • Estimated prevalence and associations of sexually transmissible bacterial enteric pathogens in asymptomatic men who have sex with men: a systematic review and meta-analysis

    by Daniel Richardson, Amber Savary-Trathen, Colin Fitzpatrick, Deborah Williams

    Objective: The reservoir of sexually transmissible bacterial enteric pathogens in asymptomatic men who have sex with men (MSM) may impact future outbreaks, and the evolution of antimicrobial resistance. We aimed to estimate the pooled prevalence and explore any factors associated with Shigella spp, Campylobacter spp, diarrhoeagenic Escherichia coli and Salmonella spp in asymptomatic MSM using the random effects model. Methods: We searched Embase, MEDLINE, CINAHL and Web of Science Core Collections for manuscripts published up to February 2024. One author screened citations and abstracts; two authors independently conducted a full-text review. We included manuscripts which measured the prevalence of Shigella spp, Campylobacter spp, diarrhoeagenic E. coli and Salmonella spp in asymptomatic MSM. Quality and risk of bias was assessed independently by two authors using the Joanna Briggs Institute critical appraisal tools. We calculated pooled prevalence and CIs using the random effects model. Results: Six manuscripts were included in the final review. The manuscripts were from Australia (n=2), the UK (n=2), the Netherlands (n=1) and the USA (n=1) and included data from 3766 asymptomatic MSM tested for bacterial enteric pathogens. The prevalence of Shigella spp was 1.1% (95% CI 0.7% to 1.7%), Campylobacter spp 1.9% (95% CI 1.5% to 2.5%), diarrhoeagenic E. coli 3.8% (95% CI 2.1% to 6.7%) and Salmonella spp 0.3% (95% CI 0.1% to 0.6%). Two manuscripts demonstrated that the detection of bacterial enteric pathogen was more frequent in asymptomatic MSM using HIV-pre-exposure prophylaxis (PrEP), living with HIV, reporting <5 new sexual partners in the past 3 months, reporting insertive oral-anal sex and group sex compared with MSM testing negative. Conclusion: Despite a small number of manuscripts, this review has estimated the pooled prevalence, and highlighted some possible associations with sexually transmissible bacterial enteric pathogens in asymptomatic MSM, which can inform future clinical guidelines, public health control strategies and research to increase our understanding of transmission and the evolution of antimicrobial resistance. PROSPERO registration number: CRD42024518700.